Literature DB >> 21176795

Advances in the medical treatment of rheumatoid arthritis.

J Michelle Kahlenberg1, David A Fox.   

Abstract

Over the past 2 decades, the treatment of rheumatoid arthritis (RA) has been revolutionized by advances in the understanding of its pathologic mechanisms and the development of drugs that target them. These newer medications have shown great promise at improving disease outcomes, but they come with notable side effects that can pose long-term treatment challenges and difficulties in the perioperative arena. In this article, the major manifestations of RA and the current medical options for management are discussed. Complications from treatment are then reviewed, and special consideration is given to perioperative medication recommendations.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21176795      PMCID: PMC3135413          DOI: 10.1016/j.hcl.2010.09.002

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  50 in total

Review 1.  Corticosteroid supplementation for adrenal insufficiency.

Authors:  Douglas B Coursin; Kenneth E Wood
Journal:  JAMA       Date:  2002-01-09       Impact factor: 56.272

Review 2.  Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.

Authors:  T Pincus; G Ferraccioli; T Sokka; A Larsen; R Rau; I Kushner; F Wolfe
Journal:  Rheumatology (Oxford)       Date:  2002-12       Impact factor: 7.580

3.  A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.

Authors:  L Sinigaglia; A Nervetti; Q Mela; G Bianchi; A Del Puente; O Di Munno; B Frediani; F Cantatore; R Pellerito; S Bartolone; G La Montagna; S Adami
Journal:  J Rheumatol       Date:  2000-11       Impact factor: 4.666

4.  Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  E M Gravallese; Y Harada; J T Wang; A H Gorn; T S Thornhill; S R Goldring
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors:  Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal:  Arthritis Rheum       Date:  2006-01

6.  High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery.

Authors:  M H Neva; A Häkkinen; H Mäkinen; P Hannonen; M Kauppi; T Sokka
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

7.  Cardiovascular death in rheumatoid arthritis: a population-based study.

Authors:  Hilal Maradit-Kremers; Paulo J Nicola; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-03

8.  Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

Authors:  Suzan M M Verstappen; Johannes W G Jacobs; Johannes W J Bijlsma; Anton H M Heurkens; Christina van Booma-Frankfort; Evert Jan ter Borg; Dick M Hofman; Maaike J van der Veen
Journal:  Arthritis Rheum       Date:  2003-07

9.  Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.

Authors:  P Hannonen; T Möttönen; M Hakola; M Oka
Journal:  Arthritis Rheum       Date:  1993-11

10.  Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs.

Authors:  Haruko Ideguchi; Shigeru Ohno; Hideaki Hattori; Akiko Senuma; Yoshiaki Ishigatsubo
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

View more
  41 in total

Review 1.  Cartilage diseases.

Authors:  Yamini Krishnan; Alan J Grodzinsky
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

2.  Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis.

Authors:  Yadhu Krishnan; Shilpa Mukundan; Suresh Akhil; Swati Gupta; Vidya Viswanad
Journal:  Adv Pharm Bull       Date:  2018-06-19

Review 3.  The Prevalence of Oropharyngeal Dysphagia in Adults Presenting with Temporomandibular Disorders Associated with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Authors:  Órla Gilheaney; Lina Zgaga; Isolde Harpur; Greg Sheaf; Liss Kiefer; Sibylle Béchet; Margaret Walshe
Journal:  Dysphagia       Date:  2017-05-16       Impact factor: 3.438

4.  Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.

Authors:  M Eissa; A El Shafey; M Hammad
Journal:  Clin Rheumatol       Date:  2017-05-22       Impact factor: 2.980

5.  Diagnostic value of high-frequency ultrasound and magnetic resonance imaging in early rheumatoid arthritis.

Authors:  Ming-Yu Wang; Xian-Bin Wang; Xue-Hui Sun; Feng-Li Liu; Sheng-Chuan Huang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

Review 6.  Cervical spine manifestations of rheumatoid arthritis: a review.

Authors:  Nathan A Shlobin; Nader S Dahdaleh
Journal:  Neurosurg Rev       Date:  2020-10-10       Impact factor: 3.042

7.  Inhibition of Cathepsin K Alleviates Autophagy-Related Inflammation in Periodontitis-Aggravating Arthritis.

Authors:  Yuan Yue; Wuwei Yin; Qin Yang; Jie Ren; Liangyu Tan; Jiajia Wang; Jie Liu; Qiuyu Lu; Handong Ding; Weicheng Zhan; Liang Hao; Min Wang
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

Review 8.  Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis.

Authors:  R Kowshik Aravilli; S Laveen Vikram; V Kohila
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

9.  Adverse outcomes following hand surgery in patients with rheumatoid arthritis.

Authors:  Victor M Menchaca-Tapia; Elizabeth M Rodríguez; Irazú Contreras-Yáñez; Martin Iglesias-Morales; Virginia Pascual-Ramos
Journal:  Plast Surg (Oakv)       Date:  2016-05-27       Impact factor: 0.947

10.  Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.

Authors:  Mark R Tanner; Michael W Pennington; Brayden H Chamberlain; Redwan Huq; Elizabeth J Gehrmann; Teresina Laragione; Pércio S Gulko; Christine Beeton
Journal:  J Pharmacol Exp Ther       Date:  2018-02-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.